CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 10 No. 8
The Ambrose/Brinck Article Reviewed 

Detection of Nodal Micrometastases in Head and Neck Cancer by Serial Sectioning and Immunostaining

By K. Kendall Pierson, MD, Department of Pathology and Laboratory Medicine
University of Florida,College of Medicine, Gainesville, Florida | August 1, 1995

Drs. Ambrosch and Brinck appropriately emphasize the problems and limitations encountered when using routine pathologic procedures to examine lymph nodes from head and neck cancer specimens. Extraordinary processing techniques have repeatedly yielded a larger number of small nodes and, on occasion, have demonstrated the presence of micrometastases. The majority of these observations come from examination of breast specimens and their axillary dissections. Labor-intensive clearing techniques have varied to some extent, but generally involve progressive removal of opaque fat with alcohol(Drug information on alcohol)ic solvents of increasing percentages culminating in absolute alcohol (100%). Final visualization involves submerging the defatted specimen in cedarwood oil, followed by careful examination and dissection of the backlighted specimen.

Pickren was among the first to advocate this procedure [1]. Subsequent studies failed to uniformly demonstrate the beneficial effect of this time-consuming, expensive procedure as it applies to the management of patients with breast carcinoma. As with breast carcinoma, conflicting reports have appeared concerning the efficacy and utility of these laborious pathologic examinations of specimens from the head and neck.

The authors correctly point out that the presence of micrometastases in the head and neck region leaves many unanswered questions. The present contribution does give us additional insights, and once again demonstrates that, in utilizing a routine technique, we overlook small metastatic deposits of carcinoma in the necks of selected patients.

Importance of Diligent Pathologic Examination

It is now clearly established that the size, number, and level of involved cervical nodes are important prognostic predictors and that extracapsular spread has a negative impact on the patient's final outcome. The authors' finding that approximately 8% of clinically negative necks (N0) harbored micrometastatic disease should alert pathologists and clinicians to the possibility of a negative clinical impact, particularly in patients with lesions of the mouth and oral pharynx. This finding reaffirms the need for diligent pathologic examination to search for small lymph nodes, since metastases were demonstrated in nodes less than 5 mm in diameter.

In the current era of worldwide cost containment, it seems imprudent to suggest the routine use of clearing, immunohistochemistry, or serial sections, as was performed by Ambrosch and Brinck. It is obvious that we should continue to search for micrometastases and particularly for extracapsular extension. I agree with the authors that it is exceedingly difficult to prospectively determine the depth of invasion; however, in our experience, the use of MRI and CT has greatly improved our T-staging sensitivity. Also, as the authors note, the accuracy of nodal assessment has shown approximately a 50% improvement.

Conclusions

I am in complete agreement with the authors' conclusion that serial microscopic sectioning of lymph nodes reveals additional micrometastases but is impractical for routine use. Selective individualized treatment of the neck in patients at risk for failure in this area seems quite rational, particularly when correlated with image analysis performed by experienced radiologists.

Cooperative studies conducted by a multidisciplinary group, including radiation oncologists, surgeons, and pathologists with expertise in this area, are needed to establish optimal treatment approaches [2]. As with all malignant disease, the goal of management for head and neck cancer remains early detection prior to metastases and, when the volume of tumor permits, ablation with minimal morbidity.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.



Petra Ambrosch, MD and Ulrich Brinck, MD


1. Pickren J: Significance of occult metastases. Cancer 121:1266-1271, 1961.

2. Janot F, Klijanienko J, Russo A, et al: Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: A prospective analysis. Br J Cancer 73:531-538, 1996.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy